252 related articles for article (PubMed ID: 12663596)
1. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.
Loukovaara S; Immonen I; Teramo KA; Kaaja R
Diabetes Care; 2003 Apr; 26(4):1193-8. PubMed ID: 12663596
[TBL] [Abstract][Full Text] [Related]
2. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
[TBL] [Abstract][Full Text] [Related]
3. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Durnwald CP; Landon MB
J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
[TBL] [Abstract][Full Text] [Related]
4. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Kitzmiller JL; Main E; Ward B; Theiss T; Peterson DL
Diabetes Care; 1999 May; 22(5):874-6. PubMed ID: 10332713
[No Abstract] [Full Text] [Related]
5. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
[TBL] [Abstract][Full Text] [Related]
6. Insulin lispro and retinopathy in pregnancy.
Edwards A
Diabetes Care; 1999 Oct; 22(10):1750-1. PubMed ID: 10526752
[No Abstract] [Full Text] [Related]
7. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).
Masson EA; Patmore JE; Brash PD; Baxter M; Caldwell G; Gallen IW; Price PA; Vice PA; Walker JD; Lindow SW
Diabet Med; 2003 Jan; 20(1):46-50. PubMed ID: 12519319
[TBL] [Abstract][Full Text] [Related]
8. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women.
Mecacci F; Carignani L; Cioni R; Bartoli E; Parretti E; La Torre P; Scarselli G; Mello G
Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):19-24. PubMed ID: 14557006
[TBL] [Abstract][Full Text] [Related]
9. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.
Heller SR; Amiel SA; Mansell P
Diabetes Care; 1999 Oct; 22(10):1607-11. PubMed ID: 10526722
[TBL] [Abstract][Full Text] [Related]
10. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
Gallen IW; Jaap A; Roland JM; Chirayath HH
Diabet Med; 2008 Feb; 25(2):165-9. PubMed ID: 18215174
[TBL] [Abstract][Full Text] [Related]
11. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy?
Buchbinder A; Miodovnik M; McElvy S; Rosenn B; Kranias G; Khoury J; Siddiqi TA
Am J Obstet Gynecol; 2000 Nov; 183(5):1162-5. PubMed ID: 11084559
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy.
Cypryk K; Sobczak M; Pertyńska-Marczewska M; Zawodniak-Szałapska M; Szymczak W; Wilczyński J; Lewiński A
Med Sci Monit; 2004 Feb; 10(2):PI29-32. PubMed ID: 14737056
[TBL] [Abstract][Full Text] [Related]
13. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
14. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
Burge MR; Waters DL; Holcombe JH; Schade DS
J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
[TBL] [Abstract][Full Text] [Related]
15. Insulin lispro, pregnancy, and retinopathy.
Bhattacharyya A; Vice PA
Diabetes Care; 1999 Dec; 22(12):2101-4. PubMed ID: 10587864
[No Abstract] [Full Text] [Related]
16. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
[TBL] [Abstract][Full Text] [Related]
17. Use of Insulin Lispro Protamine Suspension in Pregnancy.
Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
[TBL] [Abstract][Full Text] [Related]
18. Insulin lispro and regular insulin in pregnancy.
Bhattacharyya A; Brown S; Hughes S; Vice PA
QJM; 2001 May; 94(5):255-60. PubMed ID: 11353099
[TBL] [Abstract][Full Text] [Related]
19. Use of insulin glargine during pregnancy in a type 1 diabetic woman.
Devlin JT; Hothersall L; Wilkis JL
Diabetes Care; 2002 Jun; 25(6):1095-6. PubMed ID: 12032121
[No Abstract] [Full Text] [Related]
20. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
Ahmed AB; Mallias J; Home PD
Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
